These activated M1 macrophages, through the mTOR-S6K1-SREBP-1 signaling pathway, amplify disturbances in hepatic lipid metabolism in NAFLD mice, exacerbating liver injury and promoting NAFLD progression (Zhang et al., 2020). Here, RPS6KB1 is linked to metabolic dysfunction-associated steatotic liver disease.